Approach to the patient - Approach to the patient with subclinical hyperthyroidism

被引:48
作者
Cooper, David S.
机构
[1] Sinai Hosp, Div Endocrinol, Baltimore, MD 21215 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21215 USA
关键词
D O I
10.1210/jc.2006-2472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Endogenous subclinical hyperthyroidism, defined by normal circulating levels of free T-4 and T-3 and low levels of TSH, is a common clinical entity and is typically caused by the same conditions that account for the majority of cases of overt hyperthyroidism: Graves' disease, toxic multinodular goiter, and solitary autonomously functioning thyroid nodules. Subclinical hyperthyroidism has been associated with an increased risk of atrial fibrillation and mortality, decreased bone mineral density in postmenopausal women, and mild hyperthyroid symptoms. Treatment of subclinical hyperthyroidism remains controversial, given the lack of prospective randomized controlled trials showing clinical benefit with restoration of the euthyroid state. Nevertheless, it seems reasonable to treat older individuals whose serum TSH levels are less than 0.1 mU/liter and certain high-risk patients, even when the serum TSH is between 0.1 and the lower limit of the normal range.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 50 条
[1]   Subclinical hyperthyroidism as a risk factor for atrial fibrillation [J].
Auer, J ;
Scheibner, P ;
Mische, T ;
Langsteger, W ;
Eber, O ;
Eber, B .
AMERICAN HEART JOURNAL, 2001, 142 (05) :838-842
[2]  
Baskin HJ., 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, V8, P457, DOI DOI 10.4158/1934-2403-8.6.457
[3]   Risk for fracture in women with low serum levels of thyroid-stimulating hormone [J].
Bauer, DC ;
Ettinger, B ;
Nevitt, MC ;
Stone, KL .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (07) :561-568
[4]   Impaired cardiac reserve and exercise capacity in patients receiving long-term thyrotropin suppressive therapy with levothyroxine [J].
Biondi, B ;
Fazio, S ;
Cuocolo, A ;
Sabatini, D ;
Nicolai, E ;
Lombardi, G ;
Salvatore, M ;
Sacca, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (12) :4224-4228
[5]   Subclinical hyperthyroidism: clinical features and treatment options [J].
Biondi, B ;
Palmieri, EA ;
Klain, M ;
Schlumberger, M ;
Filetti, S ;
Lombardi, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2005, 152 (01) :1-9
[6]   Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients [J].
Biondi, B ;
Palmieri, EA ;
Fazio, S ;
Cosco, C ;
Nocera, M ;
Saccà, L ;
Filetti, S ;
Lombardi, G ;
Perticone, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (12) :4701-4705
[7]   The impact of overt and subclinical hyperthyroidism on skeletal muscle [J].
Brennan, Michael D. ;
Powell, Claudia ;
Kaufman, Kenton R. ;
Sun, Pi Chang ;
Bahn, Rebecca S. ;
Nair, K. Sreekumaran .
THYROID, 2006, 16 (04) :375-380
[8]   Thyroid status, cardiovascular risk, and mortality in older adults [J].
Cappola, AR ;
Fried, LP ;
Arnold, AM ;
Danese, MD ;
Kuller, LH ;
Burke, GL ;
Tracy, RP ;
Ladenson, PW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (09) :1033-1041
[9]   The association of thyroid function with cardiac mass and left ventricular hypertrophy [J].
Dörr, M ;
Wolff, B ;
Robinson, DM ;
John, U ;
Lüdemann, J ;
Meng, W ;
Felix, SB ;
Völzke, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :673-677
[10]  
Faber J, 1998, CLIN ENDOCRINOL, V48, P285